Symptomatic stenosis of the vertebrobasilar arteries: Results of extra- and intracranial stent-PTA

European Journal of Neurology

Volumn 16, Issue 1, 2009, Pages 31-36

  Seifert, T ^a   Augustin, M ^a   Klein, G E ^a   Horner, S ^a   Niederkorn, K ^a   Fazekas, F ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Intracranial stenosis; Stent PTA; Stroke; TIA; Vertebral stenosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; IODIXANOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MALE; MORBIDITY; MORTALITY; PATIENT SAFETY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; STENT; STROKE; TRANSIENT ISCHEMIC ATTACK; VERTEBRAL ARTERY STENOSIS;

ADULT; AGED; ANGIOPLASTY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STENTS; VERTEBROBASILAR INSUFFICIENCY; YOUNG ADULT;

EID: 57449106105     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2008.02297.x     Document Type: Article

References (40)

1. Caplan LR, Wityk RJ, Glass TA, et al. New England Medical Center Posterior Circulation registry. Annals of Neurology 2004 56 : 389 398.
2. Carney AL. Vertebral artery surgery: historical development, basic concepts of brain hemodynamics, and clinical experience of 102 cases. In : Carney AL, Anderson EM, eds. Diagnosis and Treatment of Brain Ischemia. New York : Raven Press, 1981 : 249 282.
3. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group. Prognosis of patients with symptomatic vertebral or basilar artery stenosis. Stroke 1998 29 : 1389 1392.
4. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. New England Journal of Medicine 2005 352 : 1305 1316.
5. Bose A, Hartmann M, Henkes H, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 2007 38 : 1531 1537.
6. Chow MM, Masaryk TJ, Woo HH, Mayberg MR, Rasmussen PA. Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: midterm analysis of clinical and radiologic predictors of neurological morbidity and mortality. AJNR. American Journal of Neuroradiology 2005 26 : 869 874.
7. Fiorella D, Chow MM, Anderson M, Woo H, Rasmussen PA, Masaryk TJ. A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery 2007 61 : 236 242 (discussion 242-3).
8. Fiorella D, Levy EI, Turk AS, et al. US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007 38 : 881 887.
9. Jiang WJ, Xu XT, Du B, et al. Long-term outcome of elective stenting for symptomatic intracranial vertebrobasilar stenosis. Neurology 2007 68 : 856 858.
10. Levy EI, Hanel RA, Boulos AS, et al. Comparison of periprocedure complications resulting from direct stent placement compared with those due to conventional and staged stent placement in the basilar artery. Journal of Neurosurgery 2003 99 : 653 660.
11. Levy EI, Horowitz MB, Koebbe CJ, et al. Transluminal stent-assisted angioplasty of the intracranial vertebrobasilar system for medically refractory, posterior circulation ischemia: early results. Neurosurgery 2001 48 : 1215 1221.
12. Qureshi AI, Kirmani JF, Hussein HM, et al. Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis. Neurosurgery 2006 59 : 1044 1051.
13. Suh DC, Kim JK, Choi JW, et al. Intracranial stenting of severe symptomatic intracranial stenosis: results of 100 consecutive patients. AJNR. American Journal of Neuroradiology 2008 29 : 781 785.
14. The SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004 35 : 1388 1392.
15. Lee CY, Yim MB. Primary stent therapy for symptomatic intracranial atherosclerotic stenosis: 1-year follow-up angiographic and midterm clinical outcomes. Journal of Neurosurgery 2006 105 : 235 241.
16. Malek AM, Higashida RT, Phatouros CC, et al. Treatment of posterior circulation ischemia with extracranial percutaneous balloon angioplasty and stent placement. Stroke 1999 30 : 2073 2085.
17. Akins PT, Kerber CW, Pakbaz RS. Stenting of vertebral artery origin atherosclerosis in high-risk patients: bare or coated? A single-center consecutive case series. The Journal of Invasive Cardiology 2008 20 : 14 20.
18. Cloud GC, Crawley F, Clifton A, McCabe DJ, Brown MM, Markus HS. Vertebral artery origin angioplasty and primary stenting: safety and restenosis rates in a prospective series. Journal of Neurology, Neurosurgery and Psychiatry 2003 74 : 586 590.
19. Dabus G, Gerstle RJ, Derdeyn CP, Cross DT III., Moran CJ. Endovascular treatment of the vertebral artery origin in patients with symptoms of vertebrobasilar ischemia. Neuroradiology 2006 48 : 917 923.
20. Kantarci F, Mihmanli I, Albayram MS, et al. Follow-up of extracranial vertebral artery stents with Doppler sonography. AJR. American Journal of Roentgenology 2006 187 : 779 787.
21. Lin YH, Juang JM, Jeng JS, Yip PK, Kao HL. Symptomatic ostial vertebral artery stenosis treated with tubular coronary stents: clinical results and restenosis analysis. Journal of Endovascular Therapy 2004 11 : 719 726.
22. Lugmayr H, Kastner M, Frohler W, Meindl S, Zisch R. Sirolimus-eluting stents for the treatment of symptomatic extracranial vertebral artery stenoses: early experience and 6-month follow-up. RoFo 2004 176 : 1431 1435.
23. Piotin M, Spelle L, Martin JB, et al. Percutaneous transluminal angioplasty and stenting of the proximal vertebral artery for symptomatic stenosis. AJNR. American Journal of Neuroradiology 2000 21 : 727 731.
24. Zaytsev AY, Stoyda AY, Smirnov VE, et al. Endovascular treatment of supra-aortic extracranial stenoses in patients with vertebrobasilar insufficiency symptoms. Cardiovascular and Interventional Radiology 2006 29 : 731 738.
25. Zavala-Alarcon E, Emmans L, Little R, Bant A. Percutaneous intervention for posterior fossa ischemia. A single center experience and review of the literature. International Journal of Cardiology 2008 127 : 70 77.
26. Albuquerque FC, Fiorella D, Han P, Spetzler RF, McDougall CG. A reappraisal of angioplasty and stenting for the treatment of vertebral origin stenosis. Neurosurgery 2003 53 : 607 614.
27. Coward LJ, McCabe DJH, Ederle J, Featherstone RL, Clifton A, Brown MM. Long-term outcome after angioplasty and stenting for symptomatic vertebral artery stenosis compared with medical treatment in the carotid and vertebral artery transluminal angioplasty study (CAVATAS). A randomized trial. Stroke 2007 38 : 1526 1530.
28. Alexandrov AV, Sloan MA, Wong LK, et al. Practice standards for transcranial Doppler ultrasound: part I - test performance. Journal of Neuroimaging 2007 17 : 11 18.
29. Baumgartner RW, Mattle HP, Schroth G. Assessment of ≥50% and <50% intracranial stenoses by transcranial color-coded duplex sonography. Stroke 1999 30 : 87 92.
30. Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI. A standardized method for measuring intracranial arterial stenosis. AJNR. American Journal of Neuroradiology 2000 21 : 643 646.
31. Ringleb PA, Allenberg J, Bruckmann H, et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 2006 368 : 1239 1247.
32. Ferguson GG, Eliasziw M, Barr HW, et al. The North American Symptomatic Carotid Endarterectomy Trial : surgical results in 1415 patients. Stroke 1999 30 : 1751 1758.
33. Zaidat OO, Klucznik R, Alexander MJ, et al. The NIH registry on use of the Wingspan stent for symptomatic70-99% intracranial arterial stenosis. Neurology 2008 70 : 1518 1524.
34. Jiang WJ, Srivastava T, Gao F, Du B, Dong KH, Xu XT. Perforator stroke after elective stenting of symptomatic intracranial stenosis. Neurology 2006 66 : 1868 1872.
35. Moufarrij NA, Little JR, Furlan AJ, Leatherman JR, Williams GW. Basilar and distal vertebral artery stenosis: long-term follow-up. Stroke 1986 17 : 938 942.
36. Glass TA, Hennessey PM, Pazdera L, et al. Outcome at 30 days in the New England Medical Center Posterior Circulation Registry. Archives of Neurology 2002 59 : 369 376.
37. Douglas JS Jr., Holmes DR Jr., Kereiakes DJ, et al. Coronary stent restenosis in patients treated with cilostazol. Circulation 2005 112 : 2826 2832.
38. Kwon SU, Cho YJ, Koo JS, et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke 2005 36 : 782 786.
39. Hellings WE, Moll FL, de Vries JP, de Bruin P, de Kleijn DP, Pasterkamp G. Histological characterization of restenotic carotid plaques in relation to recurrence interval and clinical presentation: a cohort study. Stroke 2008 39 : 1029 1032.
40. Anonymous. Stenting vs. aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS). Available at: http://clinicaltrials.gov/ct2/show/NCT00576693?term=sammpris&rank=1 (accessed 22082008).